|
|
Licensing...
Do you have a monoclonal antibody or polyclonal antibody your laboratory has manufactured?
Have you published the reagent in scientific literature?
Would you be interested in commercialising your monoclonal antibody or polyclonal antibody?
After publication, it is usual to allow peers access to your monoclonal antibody or polyclonal
antibody. However, this can involve an administrative burden and a deflection of resources in
manufacturing / dispensing samples rather than continuing research.
An alternative is to work with ImmunoKontact by licensing your reagent. Using your cell line
/ hybridoma, we can manufacture your monoclonal antibody or polyclonal antibody, purify /
conjugate and dispense it. • For more information Contact us or ...
Your reagent will be internationally available through ImmunoKontact and associated
distributors. Licensing will also generate revenue for your group / institute or provide you with access
to important reagents free of charge.
Licensing is a relatively simple process. Many monoclonal antibodies and polyclonal antibodies listed on
this web site are collaborations with researchers. We have licensing agreements with researchers in the
USA, UK, Germany and Switzerland. We are willing to consider a variety of proposals and research areas
including apoptosis, angiogenesis, cell proliferation, cell signalling, cytokines, phosphorylation and TLR.
To discuss potential licensing opportunities please Contact us.
|
